Shares in Puma Biotechnology jumped 40% after the FDA trod lightly around doubts about its filing for approval of breast cancer drug neratinib. But the talking points raised ahead of Wednesday’s ...
PUMA (XTRA:PUM) has quietly staged a sharp rebound, with the share price jumping about 34% over the past month and 12% in the past 3 months, despite still weak one year returns. See our latest ...
This article first appeared on GuruFocus. Puma (PMMAF) stock suddenly sprang to life after reports said China's Anta Sports is thinking about making a run at the German athletic brand. Bloomberg says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results